Biogen (NASDAQ: BIIB) net income
Biogen reported a net profit of $1,293m for fiscal 2025, 20.8% less than in fiscal 2024 ($1,632m). Its net margin was 13.1%. Earnings per share were $8.83.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $1,293m | −20.8% | 13.1% | $8.83 |
| 2024 | $1,632m | +40.6% | 16.9% | $11.21 |
| 2023 | $1,161m | −61.9% | 11.8% | $8.02 |
| 2022 | $3,047m | +95.8% | 29.9% | $20.96 |
| 2021 | $1,556m | −61.1% | 14.2% | $10.44 |
| 2020 | $4,001m | −32.1% | 29.8% | $24.86 |
| 2019 | $5,889m | +32.9% | 41.0% | $31.47 |
| 2018 | $4,431m | +74.5% | 32.9% | $21.63 |
| 2017 | $2,539m | −31.4% | 20.7% | $11.94 |
| 2016 | $3,703m | — | 32.3% | $16.96 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Biogen
- How much did Biogen earn in fiscal 2025?
- Biogen reported a net profit of $1,293m for fiscal 2025. In fiscal 2024 it reported a net profit of $1,632m.
- What are the earnings per share of Biogen?
- They were $8.83 in fiscal 2025, compared with $11.21 in fiscal 2024.
- What is the net margin of Biogen?
- In fiscal 2025 its net profit was 13.1% of its revenue.
- What was the most profitable year for Biogen?
- Of its last 10 fiscal years, fiscal 2019, with $5,889m.
- Where do the figures for Biogen come from?
- From the annual report (Form 10-K) that Biogen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Biogen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Biogen: the Biogen page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.